Paper Trail Health

Health Propaganda, Exposed

Repurposed drugs & anti-parasitics · Cancer · Published 2020-01-01 · By Henry Rearden

Cancer: 83-year-old with stage IVa lymphoma declines chemo, takes fenbendazole, disease regresses

Source: Abughanimeh, Evans, Kallam (Univ. of Nebraska Medical Center), Austin Hematology, 2020

Veterinary drug: Fenbendazole is a veterinary drug. It is not approved for use in humans.

Before you act: Don't stop, replace, or delay any cancer treatment without talking to your oncologist.

“Whether it's realted to Fenbendazole or other factors still unknown.”

Evidence level

CASE REPORT (single patient).

Funding

No funding statement found.

What was published

A case report of a man with diffuse large B-cell lymphoma who declined chemotherapy and took fenbendazole about 1 g daily based on self-research.

What it shows

Repeat CT showed "smaller mediastinal lymph nodes," and later PET/CT "revealed interval improvement in his disease with no new lesion seen."

What it does not show

One case; the authors say whether the regression was due to fenbendazole "or other factors still unknown." Rare spontaneous lymphoma regressions occur.

Documented counterpoints

The patient reduced the dose because of peripheral neuropathy, an adverse effect noted in the report.

Source link

Get the alert when a new entry is published.

(Newsletter signup goes live after launch.)
Paper Trail Health summarizes published studies, case reports, court filings and journalism for general information. It is not medical, legal or investment advice. Summaries quote the sources; a source's statements are its authors', not findings of this site. Don't stop, replace, or delay treatment without your doctor. Always read the linked original. See Standards & corrections and Disclaimer.